ARCHIVES

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

This article is from The Cancer Letter archive.

Vol. 11 No. 41 | October 25, 1985

Download PDF Visit The Full Archive

Related Articles

Obituaries: Jessie Gruman, 60, CFAH Founder and President; Jesse Leonard Steinfeld, 87, U.S. Surgeon General

September 5, 2014

Drug Approved in Europe For Pediatric Cancer Patients

April 24, 2009

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

October 28, 2011

In Brief: GM awards Shared By Six Scientists; Pollard Named President of Salk Institute

June 21, 1996

NCAB Votes Down Dietary Fat Study In women; Proposal highly Recommended By Study Section

September 29, 1989

In Brief: Community Planning Contracts New Review, Implementation Projects Still In Negotiation

June 4, 1976